Collaborations & Alliances
Related Searches:
Filter by:
736 - 750 of 1093 results
May 14, 2009
Regulus Therapeutics, Inc. achieved the initial milestone in its worldwide strategic alliance with GlaxoSmithKline to discover, develop and market novel microRNA-based therapeutics to treat inflammatory diseases.
Read More »
May 12, 2009
GlaxoSmithKline has agreed to extend its strategic relationship with South African-based Aspen Pharmacare Holdings Ltd., and to acquire a 16% share in the company.
Read More »
May 11, 2009
Tekmira Pharmaceuticals Corp. has entered into a product development agreement with Roche to advance Roche's first two RNA interference (RNAi) product candidates into human trials.
Read More »
May 7, 2009
Isotechnika entered a strategic investment and collaboration with Paladin Labs under which Paladin will provide Isotechnika with $7.0 million of cash upfront and $4.4 million in R&D funding during the next 12 months.
Read More »
May 5, 2009
Jubilant Biosys Ltd., a Bangalore-based subsidiary of Jubilant Organosys, has signed a research collaboration agreement with AstraZeneca focused on delivering preclinical drug candidates into AZ's pipeline.
Read More »
April 29, 2009
AMRI and CHDI Foundation entered a collaboration agreement focused on the discovery of new therapies for the treatment of Huntington’s disease (HD).
Read More »
April 24, 2009
Roche and the Spanish Lung Cancer Group (SLCG) will collaborate on the first Phase III trial to investigate Tarceva in lung cancer patients with genetic mutations in their epidermal growth factor receptor (EGFR).
Read More »
April 24, 2009
Almac Clinical Technologies and PHT Corp. have entered an alliance to improve clinical trial productivity through various education initiatives and data integration efforts aimed at reducing trial site problems and improving data collection and reporting.
Read More »
April 20, 2009
Galapagos NV has entered into a multi-year global strategic alliance with Merck, through an affiliate, to develop potential new therapies in inflammatory diseases.
Read More »
April 14, 2009
GVK Biosciences, a research services provider, has entered into a strategic alliance with Excel PharmaStudies, a Chinese CRO, to conduct clinical trials in Asia.
Read More »
April 6, 2009
Emisphere Technologies, Inc. and AAIPharma, Inc. entered a strategic alliance aimed at expanding the application of Emisphere's Eligen Technology and AAIPharma's drug development services.
Read More »
April 6, 2009
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. have extended the U.S. portion of their development and commercialization agreement for Abilify (aripiprazole), which was scheduled to end in November 2012, until the drug’s expected loss of e
Read More »
April 2, 2009
Patheon has entered into a strategic alliance agreement with Kemwell Pvt. Ltd., a provider of formulations contract manufacturing and development services based in Bangalore, India.
Read More »
April 1, 2009
Girindus signed a commercial collaboration agreement with RiboTask, a small-scale provider of oligonucleotides for use in R&D.
Read More »
April 1, 2009
Altea Therapeutics has entered into an agreement with Eli Lilly and Co. and Amylin Pharmaceuticals to develop and commercialize a daily transdermal patch delivering sustained levels of Byetta (exenatide) using Altea's PassPort Transdermal Delivery System.
Read More »
736 - 750 of 1093 results
